calendar

Apr 8, 2026grant126d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Development of full thickness human skin model for investigating the mechanis...

AI grant. $556,457. PI: Asim Ejaz

Apr 8, 2026grant126d agoALBERT EINSTEIN COLLEGE OF MEDICINE — Restoring Cognitive Flexibility After Adolescent Cocaine Exposure Using Psilo...Albert Einstein College of Medicine

DA grant. $50,114. PI: Julia Rose Benville

Apr 8, 2026grant126d agoTEMPLE UNIV OF THE COMMONWEALTH — Genetic method to selectively lesion axons or prune axonal terminals

NS grant. $237,750. PI: George M Smith

Apr 8, 2026grant126d agoINDIANA UNIVERSITY INDIANAPOLIS — DLK1 Promotes Tumorigenesis and is a Biomarker for MPNST

NS grant. $613,912. PI: David W Clapp

Apr 8, 2026grant126d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Role and regulation of methylarginine effector TDRD3 in T cell immunityCity of Hope

AI grant. $794,183. PI: Zuoming Sun

Apr 8, 2026grant126d agoCARNEGIE-MELLON UNIVERSITY — Somatostatin neurons and learning

NS grant. $455,645. PI: ALISON L BARTH

Apr 8, 2026grant126d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — A Day in the Life of the Human Brain: Investigating the Dynamic Interrelation...

MH grant. $1,004,971. PI: AVNIEL S GHUMAN

Apr 8, 2026grant126d agoYALE UNIVERSITY — Serotype re-emergence and vaccine impact in the era of next-generation pneumo...

AI grant. $792,513. PI: Daniel Martin Weinberger

Apr 8, 2026grant126d agoUNIVERSITY OF KANSAS MEDICAL CENTER — Pre-Clinical Evaluation of a Highly Selective SMARCA2 Degrader in Therapy-Res...University of Kansas Medical Center

CA grant. $398,544. PI: Priyanka Sharma

Apr 8, 2026grant126d agoSRI INTERNATIONAL — Development and Support of the Pathway Tools SoftwareSRI International

AI grant. $1,219,508. PI: PETER D KARP

Apr 8, 2026grant126d agoUNIV OF NORTH CAROLINA CHAPEL HILL — MASTL Kinase in DNA Repair and Treatment Resistance in Oral Squamous Cell Car...

DE grant. $42,358. PI: Odjo Gouttia

Apr 8, 2026grant126d agoUNIVERSITY OF TX MD ANDERSON CAN CTR — Proline tRNA biogenesis as oncogenic drivers and therapeutic target in T cell...

CA grant. $473,372. PI: Palaniraja Thandapani

Apr 8, 2026grant126d agoHEALTHPARTNERS INSTITUTE — Data-driven Development of Clinically Translatable EHR-Based Models to Estima...

MH grant. $199,747. PI: Kathleen Miley

Apr 8, 2026grant126d agoFRED HUTCHINSON CANCER CENTER — Investigating the impact of type I IFN signaling on regulatory T cell functio...

AI grant. $49,343. PI: Lakshmi S Warrier

Apr 8, 2026grant126d agoSTANFORD UNIVERSITY — Advancing iPSC-derived Thymic Epithelial Cells as Cell Therapy for T Cell Imm...Stanford University

AI grant. $809,250. PI: Katja Gabriele Weinacht

Apr 8, 2026grant126d agoUT SOUTHWESTERN MEDICAL CENTER — Mentoring in Translational Research in Inflammatory Skin Disease

AR grant. $123,108. PI: Tamia Alisha Harris-Tryon

full page →MULTIPLE VITAMINS INJECTION ADULT →fda approvals ↗

Apr 9, 2026approval125d agoMULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — FDA approvalMULTIPLE VITAMINS INJECTION ADULT

Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS

Apr 9, 2026approval125d agoVABYSMO (FARICIMAB-SVOA) — FDA approvalfaricimab

Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INTRAVITREAL

full page →faricimab →fda approvals ↗

Apr 9, 2026approval125d agoFOSFOMYCIN TROMETHAMINE — FDA approvalFOSFOMYCIN TROMETHAMINE

Sponsor: AUCTA. Form: FOR SOLUTION. Route: ORAL

full page →FOSFOMYCIN TROMETHAMINE →fda approvals ↗

Apr 9, 2026approval125d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

Apr 9, 2026approval125d agoDEFLAZACORT — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: UPSHER SMITH LABS. Form: SUSPENSION. Route: ORAL

full page →duloxetine hydrochloride DR →fda approvals ↗

Apr 9, 2026approval125d agoDULOXETINE HYDROCHLORIDE — FDA approvalduloxetine hydrochloride DR

Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

Apr 9, 2026approval125d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 9, 2026approval125d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 9, 2026approval125d agoMESNA — FDA approvalMESNA

Sponsor: RISING. Form: INJECTABLE. Route: INTRAVENOUS

full page →MESNA →fda approvals ↗

Apr 9, 2026approval125d agoONUREG (AZACITIDINE) — FDA approvalBristol-Myers Squibb Co

Sponsor: BRISTOL. Form: TABLET. Route: ORAL

Apr 9, 2026approval125d agoLEVETIRACETAM — FDA approvalAprecia Pharmaceuticals LLC

Sponsor: CHARTWELL RX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →Cosopt →fda approvals ↗

Apr 9, 2026approval125d agoCOSOPT PF (DORZOLAMIDE HYDROCHLORIDE) — FDA approvalCosopt

Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

Apr 9, 2026approval125d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL

full page →naloxone hydrochloride →fda approvals ↗

Apr 9, 2026approval125d agoREZENOPY (NALOXONE HYDROCHLORIDE) — FDA approvalnaloxone hydrochloride

Sponsor: SCIENTURE. Form: SPRAY. Route: NASAL

Apr 9, 2026approval125d agoMULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — FDA approvalMULTIPLE VITAMINS INJECTION ADULT

Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS

full page →MULTIPLE VITAMINS INJECTION ADULT →fda approvals ↗

Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

Apr 9, 2026device 510k125d agoRay Co., Ltd. — RCT800 (510k cleared)Ray Therapeutics Inc

Product code: OAS. Advisory committee: Radiology. Type: Special

Apr 9, 2026device 510k125d agoCheckcells, Inc. — Seaman Pro/Seaman (510k cleared)

Product code: POV. Advisory committee: Hematology. Type: Traditional

Apr 9, 2026device 510k125d agoInternational Life Sciences — Artelon Convenience Kits (510k cleared)

Product code: QWJ. Advisory committee: General, Plastic Surgery. Type: Traditional

Apr 9, 2026device 510k125d agoZest Anchors, LLC — LOCATOR® Angled Abutment (510k cleared)

Product code: NHA. Advisory committee: Dental. Type: Special

Apr 9, 2026device 510k125d agoCG Bio Co., Ltd. — EASYMADE-TI (510k cleared)3H Bio Co Ltd

Product code: GXN. Advisory committee: Neurology. Type: Traditional

Apr 9, 2026device 510k125d agoMaduro Medical, Inc. — Radical 6F Access Catheter (510k cleared)

Product code: QJP. Advisory committee: Cardiovascular. Type: Special

Apr 9, 2026device 510k125d agoKLISBio S.r.l. — SILKBridge (510k cleared)

Product code: JXI. Advisory committee: Neurology. Type: Traditional

Apr 9, 2026device 510k125d agoSpineart SA — SPINEART Navigation Instrument System (510k cleared)

Product code: OLO. Advisory committee: Neurology. Type: Special